To Evaluate the Efficacy of Probiotics in Improvement and Prevention of Chemotherapy Associated Side Effectes in Patients With the Breast Cancer
Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement, Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
Chemotherapy-associated side-effects would affect therapeutic effect, quality of life, and cause permanent harm to breast cancer patients. This study is designed to explore after consumption of probiotics of lactobacillus composite strain powder sachets for 6 months in breast cancer chemotherapy, and whether the improvement of meliorate the side effects, further assists patients completing the chemotherapy.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Maximum Age: 80
Healthy Volunteers: f
View:
• Stage I-III breast patients using anthracycline-based and taxane-based chemotherapy (not limited before or after chemotherapy/surgery)
• BMI \> 18 kg/m\^2
• Age between 20 and 80 years old
• Patients judged by physicians to participate in this trial and who are willing
Locations
Other Locations
Taiwan
Mackay Memorial Hospital
RECRUITING
Taipei
Contact Information
Primary
Fang-Kuei Lin, Master
meitung@genmont.com.tw
+886-6-505-2151
Backup
Wan-Hua Tsai, PhD
twh@genmont.com.tw
+886-6-505-2151
Time Frame
Start Date: 2024-04-08
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 100
Treatments
Experimental: Probiotic group
Subjects received two probiotic sachets per day
Placebo_comparator: Placebo group
Subjects received two placebo sachets per day
Related Therapeutic Areas
Sponsors
Collaborators: Mackay Memorial Hospital
Leads: GenMont Biotech Incorporation